Clinical Trial Update: Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH [Phase 2, Phase 3]

View source ↗

Summary

This entry reports that a Phase 2/Phase 3 clinical trial evaluating pentoxifylline for nonalcoholic steatohepatitis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Northwestern University | Conditions: Nonalcoholic Steatohepatitis, Liver Diseases | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-09-09